17:35 , Jul 17, 2018 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Colorectal cancer Mouse studies suggest MAPKAPK2 inhibitors could help treat colorectal cancer. In a mouse model of colorectal cancer, systemic MAPKAPK2 knockout decreased tumor number, tumor volume and intestinal polyps and increased survival compared...
07:00 , Jun 6, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Tumor necrosis factor receptor 1 (TNFRSF1A; TNFR1; CD120a) A study in mice suggests decreasing TNFRSF1A could improve the safety of tumor necrosis factor (TNF)-based...